Casdin Capital as of March 31, 2020
Portfolio Holdings for Casdin Capital
Casdin Capital holds 38 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 9.6 | $91M | 1.6M | 58.48 | |
| Sarepta Therapeutics (SRPT) | 7.0 | $66M | 670k | 97.82 | |
| Alnylam Pharmaceuticals (ALNY) | 6.8 | $64M | 585k | 108.85 | |
| Fate Therapeutics (FATE) | 6.0 | $57M | 2.6M | 22.21 | |
| Codexis (CDXS) | 6.0 | $57M | 5.1M | 11.16 | |
| Bluebird Bio (BLUE) | 5.4 | $51M | 1.1M | 45.96 | |
| Invitae (NVTAQ) | 5.0 | $48M | 3.5M | 13.67 | |
| Myokardia | 5.0 | $47M | 995k | 46.88 | |
| Agios Pharmaceuticals (AGIO) | 4.0 | $38M | 1.1M | 35.48 | |
| Constellation Pharmceticls I | 3.3 | $31M | 980k | 31.43 | |
| Twist Bioscience Corp (TWST) | 3.2 | $31M | 1.0M | 30.58 | |
| Revolution Medicines (RVMD) | 3.1 | $29M | 1.3M | 21.91 | |
| Caredx (CDNA) | 3.0 | $28M | 1.3M | 21.83 | |
| Alector (ALEC) | 2.8 | $26M | 1.1M | 24.13 | |
| Denali Therapeutics (DNLI) | 2.7 | $26M | 1.5M | 17.51 | |
| Biolife Solutions (BLFS) | 2.5 | $24M | 2.5M | 9.50 | |
| Adaptive Biotechnologies Cor (ADPT) | 2.3 | $22M | 793k | 27.78 | |
| Magenta Therapeutics | 2.0 | $19M | 3.0M | 6.28 | |
| Global Blood Therapeutics In | 1.6 | $15M | 300k | 51.09 | |
| Fulcrum Therapeutics (FULC) | 1.5 | $14M | 1.2M | 11.94 | |
| GenMark Diagnostics | 1.5 | $14M | 3.4M | 4.12 | |
| Gritstone Oncology Ord (GRTS) | 1.4 | $13M | 2.3M | 5.82 | |
| Gilead Sciences (GILD) | 1.4 | $13M | 175k | 74.76 | |
| Crispr Therapeutics (CRSP) | 1.2 | $11M | 266k | 42.41 | |
| Sage Therapeutics (SAGE) | 1.2 | $11M | 385k | 28.72 | |
| Adverum Biotechnologies | 1.2 | $11M | 1.1M | 9.77 | |
| Voyager Therapeutics (VYGR) | 1.1 | $10M | 1.1M | 9.15 | |
| Zai Lab (ZLAB) | 1.0 | $9.8M | 190k | 51.48 | |
| Allogene Therapeutics (ALLO) | 1.0 | $9.7M | 500k | 19.44 | |
| Rts/bristol-myers Squibb Compa | 1.0 | $9.5M | 2.5M | 3.80 | |
| Sangamo Biosciences (SGMO) | 1.0 | $9.3M | 1.5M | 6.37 | |
| Illumina (ILMN) | 0.9 | $8.2M | 30k | 273.13 | |
| Orchard Therapeutics Plc ads | 0.8 | $7.3M | 975k | 7.53 | |
| Black Diamond Therapeutics (BDTX) | 0.8 | $7.2M | 289k | 24.95 | |
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $5.8M | 140k | 41.17 | |
| Dermtech Ord ord (DMTK) | 0.6 | $5.6M | 572k | 9.87 | |
| Turning Point Therapeutics I | 0.4 | $3.4M | 75k | 44.67 | |
| Stoke Therapeutics (STOK) | 0.3 | $2.7M | 120k | 22.90 |
